Difficulty: Medium
Average Score: 92%
Practice
A patient with chronic heart failure is well controlled by digoxin and the plasma level of potassium is maintained constant. The following can constitute a risk factor of digitalis toxicity:
Correct answer
B
Rationale
In this scenario, the correct answer is B) Administration of quinidine as a risk factor for digitalis toxicity. Quinidine is an antiarrhythmic medication that can increase the levels of digoxin in the body by displacing it from tissue binding sites and inhibiting its renal excretion, leading to digitalis toxicity.
A) Administration of captopril is unlikely to increase the risk of digitalis toxicity. Captopril is an ACE inhibitor commonly used in heart failure patients to improve outcomes and is not directly associated with digitalis toxicity.
C) Administration of lidocaine is also not a risk factor for digitalis toxicity. Lidocaine is a local anesthetic and antiarrhythmic agent, but it does not interact significantly with digoxin to cause toxicity.
D) Administration of losartan, an angiotensin II receptor blocker (ARB), is not known to increase the risk of digitalis toxicity. Losartan is often used in heart failure patients to manage blood pressure and has a different mechanism of action compared to digoxin or quinidine.
Educationally, understanding potential drug interactions and risk factors for toxicity is crucial for healthcare professionals managing patients on multiple medications, especially those with chronic conditions like heart failure. This knowledge helps in optimizing therapy, minimizing adverse effects, and ensuring patient safety and positive outcomes.
A) Administration of captopril is unlikely to increase the risk of digitalis toxicity. Captopril is an ACE inhibitor commonly used in heart failure patients to improve outcomes and is not directly associated with digitalis toxicity.
C) Administration of lidocaine is also not a risk factor for digitalis toxicity. Lidocaine is a local anesthetic and antiarrhythmic agent, but it does not interact significantly with digoxin to cause toxicity.
D) Administration of losartan, an angiotensin II receptor blocker (ARB), is not known to increase the risk of digitalis toxicity. Losartan is often used in heart failure patients to manage blood pressure and has a different mechanism of action compared to digoxin or quinidine.
Educationally, understanding potential drug interactions and risk factors for toxicity is crucial for healthcare professionals managing patients on multiple medications, especially those with chronic conditions like heart failure. This knowledge helps in optimizing therapy, minimizing adverse effects, and ensuring patient safety and positive outcomes.